Science Explorer Back to mapMap
Discussion
Topic · Pediatrics, Perinatology and Child Health

Pharmaceutical studies and practices

Pharmaceutical studies and practices is a research topic within Pediatrics, Perinatology and Child Health. Science Explorer counts 41k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the developmental pharmacology and pediatric drug use, including topics such as off-label drug use, adverse drug reactions, clinical trials, pediatric formulations, medication adherence, regulatory framework, and neonatal intensive care. It addresses the challenges and considerations specific to drug disposition, action, and therapy in infants and children.

  • Pediatric Pharmacokinetics
  • Off-Label Drug Use
  • Adverse Drug Reactions
  • Clinical Trials
  • Pediatric Formulations
  • Drug Development
  • Population Pharmacokinetics
  • Medication Adherence
  • Regulatory Framework
  • Neonatal Intensive Care
Research works
41k
fractional, since 1950
In the world top 10%
4.2k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+1%
the tick is no change
Largest producer
United States
38% of the 10 largest, 2022-now
Pharmaceutical studies and practices

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Pharmaceutical studies and practices research?

By volume, the United States and India publish the most (1.6k and 498 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.6k works
  2. 2 India 498 works
  3. 3 United Kingdom 456 works
  4. 4 France 289 works
  5. 5 Germany 289 works
  6. 6 Spain 258 works
  7. 7 China 216 works
  8. 8 Italy 185 works
  9. 9 Brazil 182 works
  10. 10 Canada 182 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 38.0%India: 12.1%United Kingdom: 11.1%France: 7.0%6 others listed: 31.8%38%largest
United States1,568 · 38.0%India498 · 12.1%United Kingdom456 · 11.1%France289 · 7.0%6 others listed1,312 · 31.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Pharmaceutical studies and practices research?

By volume in 2022-now, Harvard University publishes the most Pharmaceutical studies and practices research, followed by United States Food and Drug Administration and University of Toronto.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 59 works
  2. 2 United States Food and Drug AdministrationUnited States 45 works
  3. 3 University of TorontoCanada 32 works
  4. 4 InsermFrance 30 works
  5. 5 University College LondonUnited Kingdom 30 works
  6. 6 Centre National de la Recherche ScientifiqueFrance 26 works
  7. 7 University of North Carolina at Chapel HillUnited States 23 works
  8. 8 Johns Hopkins UniversityUnited States 22 works
  9. 9 University of CincinnatiUnited States 21 works
  10. 10 Erasmus University RotterdamNetherlands 21 works

Who are the leading researchers in Pharmaceutical studies and practices?

The most-cited researchers publishing on Pharmaceutical studies and practices include David Moher, Theo Vos and Zulfiqar Ahmed Bhutta.

  1. 1 David Moher Canada 898k citations
  2. 2 Theo Vos United States 439k citations
  3. 3 Zulfiqar Ahmed Bhutta Pakistan 371k citations
  4. 4 John J.V. McMurray United Kingdom 349k citations
  5. 5 Cyrus Cooper United Kingdom 342k citations
  6. 6 Giuseppe Remuzzi Italy 328k citations
  7. 7 John P. A. Ioannidis United States 317k citations
  8. 8 Gordon Henry Guyatt Canada 315k citations
  9. 9 Elie A. Akl Canada 313k citations
  10. 10 Gregory Y.H. Lip United Kingdom 311k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Pharmaceutical studies and practices?

The most cited paper in Pharmaceutical studies and practices is "Arzneimittelforschung" (Barbara Miletzki, C. H. Gleiter, 2005), with 9,404 citations. Next come "Adherence to Medication" (8,018) and "Adherence to Long-Term Therapies: Evidence for Action" (6,332).

Most cited papers
#PaperReleasedCitations
1 Arzneimittelforschung Barbara Miletzki, C. H. Gleiter · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz Apr 2005 9,404
2 Adherence to Medication Lars Osterberg, Terrence F. Blaschke · New England Journal of Medicine 3 Aug 2005 8,018
3 Adherence to Long-Term Therapies: Evidence for Action Sabina De Geest, Eduardo J. Sabate · European Journal of Cardiovascular Nursing 5 Nov 2003 6,332
4 SOME QUANTITATIVE USES OF DRUG ANTAGONISTS O. ARUNLAKSHANA, H. O. Schild · British Journal of Pharmacology and Chemotherapy Open access Mar 1959 3,967
5 Arzneimittelforschung T.D. Bethke · Der Pneumologe 24 Aug 2012 3,275
All 100 most cited papers, with filters and sorting

Where is Pharmaceutical studies and practices research done?

The largest centres of Pharmaceutical studies and practices research in 2022-now are London (United Kingdom), Paris (France), New York (United States) and Boston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Silver Spring and Basel.

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 154 works
  2. 2 ParisFrance 83 works
  3. 3 New YorkUnited States 70 works
  4. 4 BostonUnited States 65 works
  5. 5 MadridSpain 61 works
  6. 6 TokyoJapan 51 works
  7. 7 BarcelonaSpain 51 works
  8. 8 MoscowRussia 47 works
  9. 9 Washington D.C.United States 47 works
  10. 10 TorontoCanada 45 works

Where it is the local speciality

  1. Silver SpringUS · 44.9 works35×
  2. BaselCH · 27.5 works7.4×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Pharmaceutical studies and practices than the world average.

See Pharmaceutical studies and practices on the map

Where is the best place to study Pharmaceutical studies and practices?

Among universities, judged by research, Harvard University, Erasmus University Rotterdam and KU Leuven score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 17.34%fractional works in this field (log) →share of work in the world top 10% →University of Washin…Erasmus University R…Harvard UniversityKU Leuven
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 75.117.4%3.5×59 -8.3%
2Erasmus University RotterdamNetherlands 71.322.2%7.6×21 -0.8%
3KU LeuvenBelgium 64.912.3%3.7×19 +23.4%
4University of WashingtonUnited States 64.527.2%2.5×15 +14.6%
5Radboud University NijmegenNetherlands 60.918.5%5.0×16 -13.1%
6University of TorontoCanada 60.89.4%3.0×32 +5.7%
7University of GroningenNetherlands 60.426.7%2.7×10 +0.5%
8University College LondonUnited Kingdom 60.110.5%3.6×30 -2.4%
9University of LiverpoolUnited Kingdom 59.613.4%6.3×19 +4.2%
10King's College LondonUnited Kingdom 55.215.8%3.2×15 +28.6%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Pharmaceutical studies and practices, country by country

Is Pharmaceutical studies and practices research growing?

Output in 2022-2025 was 1% higher than in 2018-2021, peaking in 2024. The fastest-growing topics are Pharmaceutical studies and practices.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Pharmaceutical studies and practices as a percentage of every work published that year, 0.029% in 2024.

still counting0.050%0.10%Pharmaceutical studies and practices0.025% in 202519801990200020102020

Fractional works of Pharmaceutical studies and practices over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Pharmaceutical studies and practices10.4% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Pharmaceutical studies and practices. Posts are plain text and can be reported.